Alex Zhenghong Fu, Ph.D.
Quantitative Health Sciences /JJN3-01
Telephone: (216) 445-7745
Fax: (216) 445-2781
fuz [at] ccf.org

Alex Fu

Positions:
Associate Staff (Faculty), 2011-present,
Assistant Staff (Faculty), 2005-2011
Section of Health Outcome Research and Clinical Epidemiology,
Department of Quantitative Health Sciences,
Lerner Research Institute, Cleveland Clinic

Education:
B.S., Genetics and Cell Biology, Peking University, China.
M.S., Pharmaceutical Policy and Evaluative Sciences, University of North Carolina at Chapel Hill, 2002.
Ph.D., Pharmaceutical Policy and Evaluative Sciences, University of North Carolina at Chapel Hill, 2005.

Key Interests:
Dr. Fu's primary research and teaching focus is on evaluation of healthcare economics in clinical trials and on health services and outcomes research using large observational databases. His research interests and expertise lie in pharmacoeconomics, utility assessment, health policy evaluation, propensity score method, and econometrics. His health sciences applications involve work primarily on diabetes and mental illness. Dr. Fu is currently working on several clinical trials with a focus on cost-effectiveness data collection, decision-tree modeling, and cost-effectiveness analysis.

Selected Publications:

Fu AZ, Qiu Y, Davies MJ, Radican L, Engel SS. Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes, Obesity and Metabolism 2011; 13(8): 765-769.

Fu AZ, Qiu Y, Radican L, Luo N. Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States. Quality of Life Research 2011; 20(6): 825-832.

Fu AZ, Zhang Q, Davies MJ, Pentakota S, Radican L, Seck T. Underutilization of statins in patients with type 2 diabetes in US clinical practice: A retrospective cohort study. Current Medical Research and Opinion 2011; 27(5): 1035-1040.

Hu B, Fu AZ. Predicting utility for joint health states: A general framework and a new nonparametric estimator. Medical Decision Making 2010; 30(5): E29-39.

Fu AZ, Qiu Y, Radican L, Yin DD, Mavros P. Impact of concurrent macrovascular co-morbidities on healthcare utilization in patients with type 2 diabetes in Europe: a matched study. Diabetes, Obesity and Metabolism 2010; 12(7): 631-637.

Fu AZ, Tang AS, Wang N, Du D, Jiang JZ. Effect of the Medicare part D on potentially inappropriate medication use by the older adults. Journal of the American Geriatrics Society 2010; 58(5): 944-949.

Fu AZ, Qiu Y, Radican L, Yin DD, Mavros P. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study. Cardiovascular Diabetology 2010; 9(1):15.

Fu AZ, Cantor SB, Kattan MW. Use of nomograms for personalized decision-analytic recommendations. Medical Decision Making 2010; 30(2): 267-274.

Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care 2009; 32(12):2187-92.

Li L, Fu AZ. Some methodological issues with the analysis of preference-based EQ-5D index score. Health Services and Outcomes Research Methodology 2009; 9(3): 162-176.

Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Current Medical Research and Opinion 2009; 25(6): 1413-1420.

Fu AZ, Kattan MW. Utilities should not be multiplied: Evidence from the preference-based scores in the United States. Medical Care 2008;46(9): 984-990.

Fu AZ, Li L. Thinking of having a higher predictive power for your first-stage model in propensity score analysis? Think again. Health Services and Outcomes Research Methodology 2008;8(2): 115-117.

Fu AZ, Wang N. Healthcare Expenditure and Patient Satisfaction: Cost and Quality from the Consumer’s Perspective in the United States. Current Medical Research and Opinion 2008;24(5): 1385-1394.

Liu GG, Dow WH, Fu AZ, Akin J, Lance P. Income productivity in China: On the role of health. Journal of Health Economics 2008;27(1):27-44.

Fu AZ, Dow WH, Liu GG. Propensity score and difference-in-difference methods: a study of second-generation antidepressant use in patients with bipolar disorder. Health Services and Outcomes Research Methodology 2007;7(1-2): 23-38.

Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M III. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Medical Care 2007;45(5):472-476.

Fu AZ, Liu GG, Christensen DB, Hansen RA. Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study. Value in Health 2007;10(2):128-36.

Fu AZ, Kattan MW. Racial and ethnic differences in preference-based health status measure. Current Medical Research and Opinion 2006;22(12): 2439-2448.

Fu AZ, Christensen DB, Hansen RA, Liu GG. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis. Clinical Therapeutics 2006;28(6): 979–989.

Fu AZ, Krishnan AA, Harris SD, Tompson TR. The economic burden of bipolar-related phases of depression versus mania. Drug Benefit Trends 2004;16(11): 569-575.

Fu AZ, Liu GG, Christensen DB. Inappropriate medication use and health outcomes in the elderly. Journal of the American Geriatrics Society 2004;52(11): 1934-1939.

Link to my homepage